Frontiers in Oncology Impact Factor 2025

Frontiers in Oncology is an open-access journal publishing research across the full spectrum of cancer research including basic, translational, and clinical oncology. The journal publishes rigorously peer-reviewed research across the entire spectrum of cancer research, including basic, translational, and clinical oncology. The journal covers cancer biology, cancer immunotherapy, tumor microenvironment, cancer genetics, and novel therapeutic strategies. Established in 2014 as part of the Frontiers publishing ecosystem, it has grown into one of the leading venues for disseminating oncology research findings globally.

OVERVIEWAbout Frontiers in Oncology Journal

Operating under the Frontiers Media platform, Frontiers in Oncology employs a collaborative peer-review model where editorial decisions involve both independent reviewers and academic editors. This approach aims to balance rigor with efficiency, reducing time-to-publication while maintaining scientific standards. The journal’s editorial board includes specialists from leading research institutions across North America, Europe, and Asia.

IMPACT FACTORFrontiers in Oncology Impact Factor

According to the 2025 Journal Citation Reports (Clarivate), Frontiers in Oncology has earned an Impact Factor of 3.4, positioning it in Q2 within the Oncology category. The Impact Factor reflects the ratio of citations received in 2025 to citable items published in 2023 and 2024.

The journal’s citation trajectory reflects its standing within the Oncology research community. With 111,544 total citations recorded in the Web of Science Core Collection, it ranks among the actively cited journals in its discipline. The Q2 quartile placement confirms competitive positioning relative to peer journals in the same category.

METRICSFrontiers in Oncology Journal Metrics

Beyond the Journal Impact Factor, Frontiers in Oncology is evaluated through several bibliometric indicators that together provide a rounded view of its scholarly influence:

CiteScore measures average citations per document over a four-year window, while SNIP (Source Normalized Impact per Paper) adjusts for field-specific citation practices. SJR (SCImago Journal Rank) weights citations by the prestige of the citing journal. Together, these metrics confirm Frontiers in Oncology as a well-cited venue in Oncology.

SCOPEFrontiers in Oncology Aim and Scope

The journal welcomes original research articles, systematic reviews, meta-analyses, methods papers, brief reports, and opinion pieces across its specialty sections. Core coverage areas include cancer biology, cancer immunotherapy, tumor microenvironment, cancer genetics, targeted therapy, radiation oncology, surgical oncology, cancer biomarkers. Interdisciplinary submissions connecting oncology research with computational biology, clinical medicine, or public health are particularly encouraged.

Section editors oversee manuscript evaluation within their domains, ensuring that accepted papers meet both disciplinary standards and broader methodological requirements. The journal also publishes registered reports and protocol papers, supporting reproducibility in oncology research.

SUBMISSIONSubmission Process

Authors must submit manuscripts through the Frontiers online editorial system. Initial screening checks for scope alignment, plagiarism, and formatting compliance before assignment to an academic editor. The collaborative peer review typically involves at least two independent reviewers per manuscript.

Accepted articles are published under open-access licenses (CC-BY), making them immediately available to the global research community. Article Processing Charges (APCs) apply and vary by article type; waivers are available for authors from low-income countries upon request.

FAQFrequently Asked Questions